| Dr Zbigniew Macdonald Szczepiorkowski, MD, PHD | |
|
1 Medical Center Dr, Lebanon, NH 03756-1000 | |
| (603) 653-9907 | |
| (603) 650-4845 |
| Full Name | Dr Zbigniew Macdonald Szczepiorkowski |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 33 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033142229 | NPI | - | NPPES |
| 30201854 | Medicaid | NH | |
| 1009967 | Medicaid | VT |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
News Archive
The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal of broad acceptance within the rheumatology community.
Last week, it was announced that drug addicts in England are to be given shopping vouchers for complying with treatment programmes. In this week's British Medical Journal, two experts debate whether it is acceptable for people to be paid to adhere to medication.
WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others. The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health impact globally.
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
› Verified 7 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal of broad acceptance within the rheumatology community.
Last week, it was announced that drug addicts in England are to be given shopping vouchers for complying with treatment programmes. In this week's British Medical Journal, two experts debate whether it is acceptable for people to be paid to adhere to medication.
WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others. The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health impact globally.
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zbigniew Macdonald Szczepiorkowski, MD, PHD 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 653-9907 | Dr Zbigniew Macdonald Szczepiorkowski, MD, PHD 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 653-9907 |
News Archive
The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal of broad acceptance within the rheumatology community.
Last week, it was announced that drug addicts in England are to be given shopping vouchers for complying with treatment programmes. In this week's British Medical Journal, two experts debate whether it is acceptable for people to be paid to adhere to medication.
WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others. The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health impact globally.
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
› Verified 7 days ago
Dr. Charles Harker Rhodes Iii, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Department Of Pathology, Lebanon, NH 03756 Phone: 603-650-7744 | |
Dr. Melissa Louise Petras, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Kim T Ornvold, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc - Dept Of Pathology, Lebanon, NH 03756 Phone: 603-650-7211 | |
Seth Charles Lummus, D.O. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7211 | |
Dr. Arief Suriawinata, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc - Pathology, Lebanon, NH 03756 Phone: 603-650-7048 | |
Elena Zarovnaya, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8458 |